Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation:final results of the Randomized Ischemic Mitral Evaluation (RIME) trial

The role of mitral valve repair (MVR) during coronary artery bypass grafting (CABG) in patients with moderate ischemic mitral regurgitation (MR) is uncertain. We conducted a randomized, controlled trial to determine whether repairing the mitral valve during CABG may improve functional capacity and left ventricular reverse remodeling compared with CABG alone